Tuberculosis control: current status, challenges and barriers ahead in 22 high endemic countries
- PMID: 12688094
Tuberculosis control: current status, challenges and barriers ahead in 22 high endemic countries
Abstract
Background: Despite the fact that Directly Observed Treatment Strategy (DOTS) short course is cost effective and universally recommended by WHO for effective TB control, it is beyond the financial reach of several highly endemic countries. This article aims at identifying barriers in DOTS's implementation and progress in 22 high burden countries (HBCs) from TB.
Methods: Medline abstracts, published papers and WHO reports were retrieved, critically examined and compared keeping standard parameters of TB control in view.
Results & conclusion: The increasing caseload, morbidity and mortality due to TB in high burden countries have become a major health challenge and threat to the health systems. The escalated burden of disease and deaths due to TB has posed a great threat to the international security. In the last decade little progress has been witnessed in the implementation of WHO's recommended strategy called DOTS in the 22 high burden countries. Afghanistan, Pakistan, India, Brazil, Zimbabwe, S. Africa and Uganda are some of the countries still facing challenges in the effective introduction, implementation and expansion of DOTS. Financial inabilities contribute greatly to the failure of respective national TB control programs. High burden countries are usually in the economic recession or passing through severe socio-political turmoil that has further reduced spending on TB control. Majority depends on the international assistance and put little domestic efforts. Coupled with the lack of political commitment to the issue of TB control, authors urge high TB control Program managers in HBCs to increase spending and pay a great deal of commitment to the universal implementation of DOTS, increase case detection and case management to attain their global targets.
Similar articles
-
[How to cope with the global tuberculosis burden--experiences and perspectives for Japan's international cooperation].Kekkaku. 2005 Feb;80(2):89-94. Kekkaku. 2005. PMID: 15920981 Review. Japanese.
-
Women and tuberculosis.World Health Stat Q. 1996;49(2):115-9. World Health Stat Q. 1996. PMID: 9050189 Review.
-
[Global situation of TB and its control].Kekkaku. 1999 Feb;74(2):83-90. Kekkaku. 1999. PMID: 10191600 Japanese.
-
Epidemiology of tuberculosis in the Americas: the Stop TB strategy and the millennium development goals.Int J Tuberc Lung Dis. 2009 Aug;13(8):969-75. Int J Tuberc Lung Dis. 2009. PMID: 19723376
-
Working towards TB elimination the WHO Regional Strategic Plan (2006-2015).J Commun Dis. 2006 Mar;38(3):185-90. J Commun Dis. 2006. PMID: 17373351
Cited by
-
Time delays in diagnosis of pulmonary tuberculosis: a systematic review of literature.BMC Infect Dis. 2009 Jun 11;9:91. doi: 10.1186/1471-2334-9-91. BMC Infect Dis. 2009. PMID: 19519917 Free PMC article.
-
A Slowly Growing Orange Patch on the Cheek: Diagnosis of Lupus Vulgaris 20 Years After Onset of First Skin Changes.Dermatol Ther (Heidelb). 2017 Mar;7(1):181-185. doi: 10.1007/s13555-016-0158-x. Epub 2016 Nov 25. Dermatol Ther (Heidelb). 2017. PMID: 27888486 Free PMC article.
-
SMS reminders to improve the tuberculosis cure rate in developing countries (TB-SMS Cameroon): a protocol of a randomised control study.Trials. 2014 Jan 24;15:35. doi: 10.1186/1745-6215-15-35. Trials. 2014. PMID: 24460827 Free PMC article. Clinical Trial.
-
SMS reminders to improve adherence and cure of tuberculosis patients in Cameroon (TB-SMS Cameroon): a randomised controlled trial.BMC Public Health. 2018 May 2;18(1):583. doi: 10.1186/s12889-018-5502-x. BMC Public Health. 2018. PMID: 29720146 Free PMC article. Clinical Trial.
MeSH terms
LinkOut - more resources
Medical